Regeneron Pharmaceuticals Inc (REGN)

Cash ratio

		Sep 30, 2025	Jun 30, 2025	Mar 31, 2025	Dec 31, 2024	Sep 30, 2024	Jun 30, 2024	Mar 31, 2024	Dec 31, 2023	Sep 30, 2023	Jun 30, 2023	Mar 31, 2023	Dec 31, 2022	Sep 30, 2022	Jun 30, 2022	Mar 31, 2022	Dec 31, 2021	Sep 30, 2021	Jun 30, 2021	Mar 31, 2021	Dec 31, 2020
Cash and cash equivalents	US$ in thousands	2,506,400	1,995,800	3,090,200	2,488,200	2,011,800	1,920,700	2,602,000	2,730,000	2,152,300	1,937,200	3,916,300	3,105,900	3,491,300	3,395,100	3,345,700	2,885,600	3,432,400	2,072,200	1,437,900	2,193,700
Short-term investments	US$ in thousands	5,937,200	5,473,800	5,259,200	6,524,300	7,784,700	7,888,300	7,917,500	8,114,800	7,761,300	6,990,500	5,043,400	4,636,400	3,530,400	4,171,300	3,704,900	2,809,100	2,355,200	1,838,600	2,065,900	1,393,300
Total current liabilities	US$ in thousands	4,425,100	3,667,000	3,566,600	3,944,300	3,661,000	3,508,600	3,580,900	3,423,400	3,598,600	3,104,400	3,100,100	3,141,300	2,879,200	3,033,900	3,007,600	3,932,500	3,714,800	3,732,400	3,217,800	2,806,800
Cash ratio		1.91	2.04	2.34	2.28	2.68	2.80	2.94	3.17	2.75	2.88	2.89	2.46	2.44	2.49	2.34	1.45	1.56	1.05	1.09	1.28